Human Papillomavirus Prophylactic Vaccination Improves Reproductive Outcome in Infertile Patients with HPV Semen Infection: a Retrospective Study

Overview

Journal Sci Rep

Specialty Science

Date 2018 Jan 19

PMID 29343824

Citations 22

Authors

Andrea Garolla

Luca De Toni

Alberto Bottacin

Umberto Valente

Maurizio De Rocco Ponce

Andrea Di Nisio

Carlo Foresta

Affiliations

Soon will be listed here.

Abstract

In this study we aimed to evaluate the effect on reproductive outcome of HPV vaccination in male subjects of infertile couples with HPV semen infection. In this single-center study, we retrospectively enrolled 151 infertile couples with detection of HPV in semen, attending our Hospital Unit of Andrology between January 2013 and June 2015, counseled to receive adjuvant HPV vaccination. Seventy-nine accepted vaccination (vaccine group) whilst 72 did not (control group). Our protocol of follow-up, aimed to evaluate HPV viral clearance, consisted in semen analysis, INNO-LiPA and FISH for HPV in semen cells after 6 and 12 months from basal evaluation. Spontaneous pregnancies, miscarriages and live births were recorded. Progressive sperm motility and anti-sperm antibodies were improved in the vaccine group at both time points (p < 0,05 vs control arm). Forty-one pregnancies, 11 in the control group and 30 in the vaccine group, were recorded (respectively 15% and 38,9%, p < 0,05) and resulted into 4 deliveries and 7 miscarriages (control group) and 29 deliveries and one miscarriage (vaccine group, p < 0,05 vs control group). HPV detection on sperms was predictive of negative pregnancy outcome. Adjuvant vaccination associated with enhanced HPV healing in semen cells and increased rate of natural pregnancies and live births.

Citing Articles

Impact of Human Papillomavirus (HPV) on Male and Female Fertility.

Chenafi-Adham S, Boussetta-Charfi O, Pillet S, Bourlet T Pathogens. 2025; 13(12.

PMID: 39770336 PMC: 11728800. DOI: 10.3390/pathogens13121076.

Recurrent miscarriage and male factor infertility: diagnostic and therapeutic implications. A narrative review.

Gkeka K, Symeonidis E, Tsampoukas G, Moussa M, Issa H, Kontogianni E Cent European J Urol. 2024; 76(4):336-346.

PMID: 38230311 PMC: 10789276. DOI: 10.5173/ceju.2023.74.

Human Papillomavirus and Male Infertility: What Do We Know?.

Sucato A, Butta M, Bosco L, Gregorio L, Perino A, Capra G Int J Mol Sci. 2023; 24(24).

PMID: 38139389 PMC: 10744208. DOI: 10.3390/ijms242417562.

Garolla A, Graziani A, Grande G, Ortolani C, Ferlin A J Endocrinol Invest. 2023; 47(2):261-274.

PMID: 37770654 PMC: 10859347. DOI: 10.1007/s40618-023-02192-3.

Viruses, bacteria and parasites: infection of the male genital tract and fertility.

Guiton R, Drevet J Basic Clin Androl. 2023; 33(1):19.

PMID: 37468865 PMC: 10357631. DOI: 10.1186/s12610-023-00193-z.

References

La Vignera S, Vicari E, Condorelli R, Franchina C, Scalia G, Morgia G . Prevalence of human papilloma virus infection in patients with male accessory gland infection. Reprod Biomed Online. 2015; 30(4):385-91. DOI: 10.1016/j.rbmo.2014.12.016. View

Oakeshott P, Hilton S, Hay P . Treatment and causes of female infertility. Lancet. 1994; 344(8918):334. View

Foresta C, Bertoldo A, Garolla A, Pizzol D, Mason S, Lenzi A . Human papillomavirus proteins are found in peripheral blood and semen Cd20+ and Cd56+ cells during HPV-16 semen infection. BMC Infect Dis. 2013; 13:593. PMC: 3878630. DOI: 10.1186/1471-2334-13-593. View

Day P, Kines R, Thompson C, Jagu S, Roden R, Lowy D . In vivo mechanisms of vaccine-induced protection against HPV infection. Cell Host Microbe. 2010; 8(3):260-70. PMC: 2939057. DOI: 10.1016/j.chom.2010.08.003. View

Foresta C, Noventa M, De Toni L, Gizzo S, Garolla A . HPV-DNA sperm infection and infertility: from a systematic literature review to a possible clinical management proposal. Andrology. 2014; 3(2):163-73. DOI: 10.1111/andr.284. View

Garolla A, Pizzol D, Bertoldo A, De Toni L, Barzon L, Foresta C . Association, prevalence, and clearance of human papillomavirus and antisperm antibodies in infected semen samples from infertile patients. Fertil Steril. 2012; 99(1):125-131.e2. DOI: 10.1016/j.fertnstert.2012.09.006. View

Gimenes F, Souza R, Bento J, Teixeira J, Maria-Engler S, Bonini M . Male infertility: a public health issue caused by sexually transmitted pathogens. Nat Rev Urol. 2014; 11(12):672-87. DOI: 10.1038/nrurol.2014.285. View

Luttmer R, Dijkstra M, Snijders P, Hompes P, Pronk D, Hubeek I . Presence of human papillomavirus in semen in relation to semen quality. Hum Reprod. 2016; 31(2):280-6. DOI: 10.1093/humrep/dev317. View

Matovina M, Husnjak K, Milutin N, Ciglar S, Grce M . Possible role of bacterial and viral infections in miscarriages. Fertil Steril. 2004; 81(3):662-9. DOI: 10.1016/j.fertnstert.2003.08.020. View

10.

Barzon L, Militello V, Pagni S, Palu G . Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes. J Clin Virol. 2012; 55(3):256-61. DOI: 10.1016/j.jcv.2012.07.013. View

11.

Chaturvedi A, Engels E, Pfeiffer R, Hernandez B, Xiao W, Kim E . Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29(32):4294-301. PMC: 3221528. DOI: 10.1200/JCO.2011.36.4596. View

12.

Panagiotou O, Befano B, Gonzalez P, Rodriguez A, Herrero R, Schiller J . Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. BMJ. 2015; 351:h4358. PMC: 4561367. DOI: 10.1136/bmj.h4358. View

13.

Apter D, Wheeler C, Paavonen J, Castellsague X, Garland S, Skinner S . Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial. Clin Vaccine Immunol. 2015; 22(4):361-73. PMC: 4375348. DOI: 10.1128/CVI.00591-14. View

14.

DSouza G, Kreimer A, Viscidi R, Pawlita M, Fakhry C, Koch W . Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356(19):1944-56. DOI: 10.1056/NEJMoa065497. View

15.

Hermonat P, Han L, Wendel P, Quirk J, Stern S, Lowery C . Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens. Virus Genes. 1997; 14(1):13-7. DOI: 10.1023/a:1007975005433. View

16.

Conde-Ferraez L, Chan May A, Carrillo-Martinez J, Ayora-Talavera G, Gonzalez-Losa M . Human papillomavirus infection and spontaneous abortion: a case-control study performed in Mexico. Eur J Obstet Gynecol Reprod Biol. 2013; 170(2):468-73. DOI: 10.1016/j.ejogrb.2013.07.002. View

17.

Ferraretti A, La Marca A, Fauser B, Tarlatzis B, Nargund G, Gianaroli L . ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011; 26(7):1616-24. DOI: 10.1093/humrep/der092. View

18.

Garolla A, Pizzol D, Vasoin F, Barzon L, Bertoldo A, Foresta C . Counseling reduces HPV persistence in coinfected couples. J Sex Med. 2013; 11(1):127-35. DOI: 10.1111/jsm.12358. View

19.

Foresta C, Garolla A, Parisi S, Ghezzi M, Bertoldo A, Di Nisio A . HPV prophylactic vaccination in males improves the clearance of semen infection. EBioMedicine. 2015; 2(10):1487-93. PMC: 4634690. DOI: 10.1016/j.ebiom.2015.09.005. View

20.

Harper D, Franco E, Wheeler C, Moscicki A, Romanowski B, Roteli-Martins C . Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006; 367(9518):1247-55. DOI: 10.1016/S0140-6736(06)68439-0. View